New FDA Commissioner Scott Gottlieb, MD, says the agency wants to know whether abuse-deterrent prescription opioids "are having their intended impact on limiting abuse and helping to curb the epidemic." To help get a meaningful answer, Gottlieb has called a public meeting for July 10 and 11,…Read More >
In its second move in a week aimed at beefing up regulations concerning the nation’s opioid addiction epidemic, the Food and Drug Administration (FDA) has introduced guidelines for the development of abuse-deterrent formulations for all approved generic oral prescription opioids. Earlier in…Read More >
Call to speak to one of our experienced & caring detox advisors today!
The FDA has said no-go to Purdue Pharma's plan to bring a new immediate-release oxycodone painkiller to market. But the same panelists have approved an extended-release oxycodone painkiller from Collegium Pharmaceutical. Purdue's new painkiller, to be called Avridi if approved, was planned as…Read More >
Find Out If Your Insurance Will Pay
- Assessment: Do I Need Detox or Rehab?
- What is Detox?
- How Long Will It Take?
- What Will It Cost?
- Symptoms of Withdrawal
- Our Facility
- Contact Us